Actively Recruiting

Phase Not Applicable
Age: 40Years - 80Years
All Genders
NCT07518290

Remotely Supervised Home-based Transcranial Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease

Led by Shanghai University of Sport · Updated on 2026-04-14

68

Participants Needed

2

Research Sites

103 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if home-based temporal interference stimulation (TIS) works to improve motor symptoms in people with Parkinson's disease (PD). It will also learn about the safety of this treatment. The main questions it aims to answer are: 1. Does home-based TIS improve movement problems such as slow movement, stiffness, and walking difficulty? 2. Are the effects maintained after the treatment ends? 3. What medical problems (adverse events) occur during treatment? Researchers will compare active TIS to a sham treatment (a look-alike procedure that does not deliver active stimulation) to see if TIS works. Participants will: 1. Receive active TIS or sham stimulation once a day for 4 weeks at home under remote supervision 2. Visit the clinic at specific time points for movement assessments 3. Complete online questionnaires about symptoms and quality of life

CONDITIONS

Official Title

Remotely Supervised Home-based Transcranial Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease

Who Can Participate

Age: 40Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Parkinson's disease according to established clinical criteria
  • Mild-to-moderate disease severity, defined as Hoehn and Yahr stage 1.5-3
  • Age between 40 and 80 years
  • Stable anti-parkinsonian medication regimen
  • Ability to walk unaided for at least 2 minutes
Not Eligible

You will not qualify if you...

  • Contraindications to temporal interference stimulation such as metal implants or pacemakers
  • Current use of deep brain stimulation (DBS)
  • Significant cognitive impairment including Alzheimer's disease, dementia, or Montreal Cognitive Assessment (MoCA) score below 21
  • Diagnosis of other neurological diseases such as multiple sclerosis or previous stroke
  • Severe lower-extremity arthritis, pain, or orthopedic problems that affect walking
  • Physician-diagnosed schizophrenia or other psychiatric illness
  • Unwillingness to cooperate or participate in the study protocol

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Shanghai University of Sport

Shanghai, Shanghai Municipality, China, 200438

Not Yet Recruiting

2

Shanghai University of Sport

Shanghai, Shanghai Municipality, China, 200438

Actively Recruiting

Loading map...

Research Team

Y

Yu Liu, Prof.

CONTACT

Z

Zijun Lu

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here